Showing results (31-40 of 107) with videos related to
Sort By:
Pageof 11
Journal of Patient Safety|November 1, 2017
Learning From Morbidity and Mortality Conferences: Focus and Sustainability of Lessons for Patient CareMarit S de Vos, Jaap F Hamming, Perla J Marang-van de MheenBMJ Quality & Safety|January 5, 2018
The problem with using patient complaints for improvementMarit S de Vos, Jaap F Hamming, Perla J Marang-van de MheenPlos Neglected Tropical Diseases|May 12, 2021
The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villagesAnneke S de Vos, Wilma A Stolk, Luc E Coffeng, et al.Plos One|May 26, 2018
Correction: Predicting anti-RhD titers in donors: Boostering response and decline rates are personalAnneke S de Vos, C Ellen van der Schoot, Dimitris Rizopoulos, et al.Plos Neglected Tropical Diseases|October 9, 2018
The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasisAnneke S de Vos, Wilma A Stolk, Sake J de Vlas, et al.Biochemical and Biophysical Research Communications|March 17, 1995
Transgenic mice overexpressing human copper/zinc-superoxide dismutase (Cu/Zn SOD) are not resistant to endotoxic shockS de Vos, C J Epstein, E Carlson, et al.Epidemics|June 6, 2012
Determinants of persistent spread of HIV in HCV-infected populations of injecting drug usersAnneke S de Vos, Jannie J van der Helm, Maria Prins, et al.Experimental Hematology|October 1, 1987
Inhibition of in vitro hematopoiesis by hepatitis A virusF W Busch, S de Vos, B Flehmig, et al.Plos One|April 27, 2018
Predicting anti-RhD titers in donors: Boostering response and decline rates are personalAnneke S de Vos, C Ellen van der Schoot, Dimitris Rizopoulos, et al.European Journal of Immunology|October 1, 1992
Leukotriene B4 transcriptionally activates interleukin-6 expression involving NK-chi B and NF-IL6M A Brach, S de Vos, C Arnold, et al.Pageof 11